Latest news
25 items- SECSEC Form 10-Q filed by Pressure BioSciences, Inc.10-Q - PRESSURE BIOSCIENCES INC (0000830656) (Filer)
- INSIDERDirector Peterson Jeffrey N acquired $1,670 worth of shares (59,652 units at $0.03), increasing direct ownership by 72% to 142,084 units (SEC Form 4)4 - PRESSURE BIOSCIENCES INC (0000830656) (Issuer)
- INSIDERDirector Urdea Michael S acquired $404 worth of shares (14,429 units at $0.03), increasing direct ownership by 44% to 47,588 units (SEC Form 4)4 - PRESSURE BIOSCIENCES INC (0000830656) (Issuer)
- INSIDERPresident, CEO Schumacher Richard T acquired $641 worth of shares (22,878 units at $0.03), increasing direct ownership by 38% to 82,967 units (SEC Form 4)4 - PRESSURE BIOSCIENCES INC (0000830656) (Issuer)
- INSIDERDirector Lazarev Alexander V acquired $528 worth of shares (18,863 units at $0.03), increasing direct ownership by 102% to 37,400 units (SEC Form 4)4 - PRESSURE BIOSCIENCES INC (0000830656) (Issuer)
- SECSEC Form 10-Q filed by Pressure BioSciences, Inc.10-Q - PRESSURE BIOSCIENCES INC (0000830656) (Filer)
- SECSEC Form NT 10-Q filed by Pressure BioSciences, Inc.NT 10-Q - PRESSURE BIOSCIENCES INC (0000830656) (Filer)
- SECPressure BioSciences, Inc. filed SEC Form 8-K: Other Events8-K - PRESSURE BIOSCIENCES INC (0000830656) (Filer)
- SECPressure BioSciences, Inc. filed SEC Form 8-K: Leadership Update8-K - PRESSURE BIOSCIENCES INC (0000830656) (Filer)
- PRPressure BioSciences, Inc. to Host Business and Financial Update on Thursday, June 20th at 4:30pm ETCANTON, Mass., June 18, 2024 (GLOBE NEWSWIRE) -- Pressure BioSciences, Inc. (OTCQB:PBIO) ("PBIO" and the "Company") today announced that the Company will host a teleconference to update investors and other stakeholders in the Company on a number of business and financial topics. The teleconference is scheduled for Thursday, June 20, 2024 at 4:30pm ET. Topics to be discussed include: FY 2023 financial and business results.FY 2024 financial and business outlook.Status of Company's relocation to its new manufacturing facility.Status of Company's new Joint Venture Program.Update on Uncle Bud's Health and WellnessProduct expansion – expected Q3/Q4 2024 release of new nanoemulsified products, i
- PRPressure BioSciences, Inc. to Host Business and Financial Update on Wednesday, June 19th at 4:30pm ETSOUTH EASTON, Mass., June 13, 2024 (GLOBE NEWSWIRE) -- Pressure BioSciences, Inc. (OTCQB:PBIO) ("PBIO" and the "Company") today announced that the Company will host a teleconference to update investors and other stakeholders in the Company on a number of business and financial topics. The teleconference is scheduled for Wednesday, June 19, 2024 at 4:30 PM ET. The topics to be discussed include but are not limited to: FY 2023 financial and business results.FY 2024 financial and business outlook.Status of Company's relocation to its new manufacturing facility.Update on Uncle Bud's Health and WellnessProduct expansion – expected Q3/Q4 2024 commercial release of new nanoemulsified products: N
- SECSEC Form 10-K filed by Pressure BioSciences, Inc.10-K - PRESSURE BIOSCIENCES INC (0000830656) (Filer)
- SECPressure BioSciences, Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders8-K - PRESSURE BIOSCIENCES INC (0000830656) (Filer)
- PRUncle Bud's Health and Wellness to Expand New Premium Collection with Novel Products for Sleep, Memory, Pain, Immunity, Feminine Hygiene, and Sexual WellnessSOUTH EASTON, Mass., April 11, 2024 (GLOBE NEWSWIRE) -- Pressure BioSciences, Inc. (OTCQB:PBIO) ("PBIO" or the "Company"), a leading innovator in high-pressure nanotechnology and a pioneer in the development of novel, broadly-enabling, pressure-based instruments and nanoemulsion products and services for the health & wellness, food & beverage, nutraceutical, cosmeceutical, and other industries, today revealed that its wholly-owned Uncle Bud's Health & Wellness direct-to-consumer ("DTC") subsidiary ("Uncle Bud's") has announced an expansion of products and categories in 2024 to its recently formed "Premium Collection" of state-of-the-art nanoemulsified products. Premium Collection products
- PRPressure BioSciences' Uncle Bud's Subsidiary Reports Significant Demand for New UltraShear CBD Body Revive Spray – First Product in New "Premium Collection"PBIO Receives Critical Processor License for Industrial Hemp in MA.New License and Relocation to Enhanced Manufacturing Facility Allows Company to Supplement Production with West Coast Partner to Manage Anticipated Onset of Purchase Order Increases. CANTON, Mass., April 02, 2024 (GLOBE NEWSWIRE) -- Pressure BioSciences, Inc. (OTCQB:PBIO) ("PBIO" or the "Company"), a leading innovator in high-pressure nanotechnology and a pioneer in the development of novel, broadly-enabling, pressure-based instruments and nanoemulsion products and services for the health & wellness, food & beverage, nutraceutical, cosmeceutical, and other industries, today announced that its wholly-owned Uncle Bud's H
- SECSEC Form NT 10-K filed by Pressure BioSciences, Inc.NT 10-K - PRESSURE BIOSCIENCES INC (0000830656) (Filer)
- INSIDERUrdea Michael S acquired $460 worth of shares (2,872 units at $0.16), increasing direct ownership by 9% to 33,159 units (SEC Form 4)4 - PRESSURE BIOSCIENCES INC (0000830656) (Issuer)
- INSIDERSchumacher Richard T acquired $729 worth of shares (4,554 units at $0.16), increasing direct ownership by 8% to 60,089 units (SEC Form 4)4 - PRESSURE BIOSCIENCES INC (0000830656) (Issuer)
- INSIDERPollack Kevin acquired $466 worth of shares (2,914 units at $0.16), increasing direct ownership by 9% to 36,787 units (SEC Form 4)4 - PRESSURE BIOSCIENCES INC (0000830656) (Issuer)
- INSIDERPeterson Jeffrey N acquired $1,900 worth of shares (11,874 units at $0.16), increasing direct ownership by 17% to 82,432 units (SEC Form 4)4 - PRESSURE BIOSCIENCES INC (0000830656) (Issuer)
- INSIDERMangiardi Vito J acquired $100 worth of shares (625 units at $0.16), increasing direct ownership by 4% to 16,104 units (SEC Form 4)4 - PRESSURE BIOSCIENCES INC (0000830656) (Issuer)
- INSIDERLazarev Alexander V acquired $601 worth of shares (3,755 units at $0.16), increasing direct ownership by 25% to 18,537 units (SEC Form 4)4 - PRESSURE BIOSCIENCES INC (0000830656) (Issuer)
- SECSEC Form DEF 14A filed by Pressure BioSciences, Inc.DEF 14A - PRESSURE BIOSCIENCES INC (0000830656) (Filer)
- PRUncle Bud's Health & Wellness Experiencing Powerful Growth One Month Following Acquisition by Pressure BioSciences, Inc.SOUTH EASTON, Mass., Feb. 26, 2024 (GLOBE NEWSWIRE) -- Pressure BioSciences, Inc. (OTCQB:PBIO) ("PBIO" or the "Company"), a pioneer in the development and distribution of broadly enabling pressure-based instruments, consumables, and specialty process development and testing services across global industries, including health and wellness, nutraceuticals, food and beverage, cosmetics, biotherapeutics, and more, is excited to announce promising early financial results from its January 19, 2024 acquisition of Uncle Bud's Health & Wellness ("UB"). Key highlights from Uncle Bud's first month following its acquisition by PBIO include: Amazon Business Rapid Growth: Amazon sales have surged, inc
- PRPressure BioSciences Completes Relocation into New Manufacturing Facility, Consolidating R&D with Expanded UltraShear Equipment Development and Contract ManufacturingCANTON, Mass., Feb. 15, 2024 (GLOBE NEWSWIRE) -- Pressure BioSciences, Inc. (OTCQB:PBIO) ("PBIO" or the "Company"), a leading innovator in high-pressure nanotechnology and a pioneer in the development of novel, broadly-enabling, pressure-based instruments and nanoemulsion products and services for the health & wellness, food & beverage, pharmaceutical, and other industries, today celebrated a significant milestone in its accelerating growth journey. The Company announced the consolidation of its Boston area operations, uniting all of its personnel into a single, cutting-edge facility designed to accommodate expanded R&D capabilities, advanced equipment development and production, formulati
PBIO FAQ
6 questionsWhat does Pressure BioSciences, Inc. do?
Pressure BioSciences, Inc. develops and sells pressure-based platform solutions in the Americas, Europe, Asia, Africa, and Australia. Its pressure cycling technology (PCT) technology uses alternating cycles of hydrostatic pressure between ambient and ultra-high levels to control the actions of molecules in biological samples, including cells and tissues from human, animal, plant, and microbial sources. The company offers Barocycler instrumentations comprising Barocycler 2320EXT, Barocycler HUB880, Barocycler HUB440, and The Shredder SG3. It also distributes cell disruption equipment, parts...Where does PBIO stock trade?
Pressure BioSciences, Inc. (PBIO) is listed on NASDAQ.What sector and industry is PBIO in?
Pressure BioSciences, Inc. operates in the n/a sector.When did Pressure BioSciences, Inc. go public?
Pressure BioSciences, Inc. (PBIO) completed its IPO in n/a.What companies are similar to PBIO?
Notable peers in the same industry include CBOE (Cboe Global Markets, Inc.), HCXY (Hercules Capital, Inc.), PCI (PIMCO Dynamic Credit and Mortgage Income Fund), BXS (BancorpSouth Bank), AJAX (Ajax I). Compare PBIO side-by-side with any of them on Quantisnow.How can I track PBIO on Quantisnow?
Quantisnow aggregates Pressure BioSciences, Inc.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow PBIO to receive live email and push alerts on every new disclosure.